Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Tax Provisions (2020 - 2022)

Historic Tax Provisions for Whitehawk Therapeutics (WHWK) over the last 3 years, with Q4 2022 value amounting to -$9000.0.

  • Whitehawk Therapeutics' Tax Provisions changed N/A to -$9000.0 in Q4 2022 from the same period last year, while for Dec 2023 it was -$9000.0, marking a year-over-year change of. This contributed to the annual value of $2000.0 for FY2021, which is 0.0% changed from last year.
  • As of Q4 2022, Whitehawk Therapeutics' Tax Provisions stood at -$9000.0.
  • In the past 5 years, Whitehawk Therapeutics' Tax Provisions registered a high of $9000.0 during Q2 2022, and its lowest value of -$9000.0 during Q4 2022.
  • In the last 3 years, Whitehawk Therapeutics' Tax Provisions had a median value of $1500.0 in 2020 and averaged $750.0.
  • Over the last 5 years, Whitehawk Therapeutics' Tax Provisions had its largest YoY gain of 35000.0% in 2022, and its largest YoY loss of 35000.0% in 2022.
  • Over the past 3 years, Whitehawk Therapeutics' Tax Provisions (Quarter) stood at $1000.0 in 2020, then surged by 100.0% to $2000.0 in 2021, then crashed by 550.0% to -$9000.0 in 2022.
  • Its last three reported values are -$9000.0 in Q4 2022, $9000.0 for Q2 2022, and $2000.0 during Q2 2021.